Abeona Therapeutics Inc (ABEO)

R&D Expenses

$25.50M

TTM · Period ending: · USD

ABEO logo

ABEO R&D Expenses

Latest reported$25.50M
ABEO TTM R&D Expenses ($1.40M → $25.50M)
High-resolution chart · PNG

ABEO r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Abeona Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
25,504,000
26,426,000
26,812,000
29,094,000
33,819,000
37,094,000
34,360,000
32,745,000
30,952,000
30,257,000
31,091,000
29,984,000
28,326,000
26,461,000
30,349,000
36,909,000
40,475,000
42,350,000
38,738,000
35,149,000
34,062,000
31,638,000
63,055,000
64,686,000
67,634,000
77,832,000
49,835,000
49,371,000
51,604,000
43,213,000
39,638,000
34,934,000
25,061,000
22,953,000
16,989,000
14,320,000
13,788,000
10,998,000
10,655,000
9,835,000
8,671,000
6,263,000
4,861,000
2,679,000
1,171,000
642,000
333,000
426,000
589,000
705,000
884,000
1,054,000
1,126,000
1,583,000
2,234,000
2,893,000
3,648,000
4,054,000
4,200,000
3,874,000
4,010,000
3,683,000
3,349,000
3,545,000
2,907,000
2,756,000
2,657,000
2,335,000
3,058,000
3,655,000
12,613,000
13,178,000
12,490,000
11,834,000
2,602,000
1,816,000
1,599,000
1,710,000
2,053,000
900,000
931,000
1,737,000
2,300,000
4,755,000
5,751,000
5,592,000
5,417,000
5,379,000
5,227,000
5,443,000
6,096,000
6,357,000
7,284,000
7,498,000
7,024,000
6,059,000
5,173,000
4,494,000
4,174,000
4,614,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.